VeriMomIst sodium c12-15 pareth-7 sulfonate in der Schwangerschaft sicher?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive warning found for sodium C12–15 pareth-7 sulfonate. Regulatory and safety-assessment sources treat ethoxylated alkyl sulfonate surfactants as low systemic-reprotoxicity in cosmetic use (CIR / SCCS style conclusions) and there are no peer-reviewed reports of teratogenicity or human reproductive effects for this specific ingredient. Dermal cosmetic use can give low but measurable exposure; therefore exposure score is 1. Sources: ECHA Annex VI (no harmonised classification), CIR/SCCS style safety literature, PubChem/CosIng entries (no reproductive flags).
Related ingredients
Frequently asked questions
- Ist sodium c12-15 pareth-7 sulfonate in der Schwangerschaft sicher?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR reproductive warning found for sodium C12–15 pareth-7 sulfonate. Regulatory and safety-assessment sources treat ethoxylated alkyl sulfonate surfactants as low systemic-reprotoxicity in cosmetic use (CIR / SCCS style conclusions) and there are no peer-reviewed reports of teratogenicity or human reproductive effects for this specific ingredient. Dermal cosmetic use can give low but measurable exposure; therefore exposure score is 1. Sources: ECHA Annex VI (no harmonised classification), CIR/SCCS style safety literature, PubChem/CosIng entries (no reproductive flags).
- Ist sodium c12-15 pareth-7 sulfonate während des Stillens sicher?
- No evidence of reproductive or lactation-related toxicity or known mechanisms for transfer into breast milk for this ingredient; no harmonised hazard classification. Dermal cosmetic use implies low but measurable maternal systemic exposure, so a low exposure score is used. Sources: ECHA records (no harmonised classification), CosIng/PubChem (no lactation concerns), absence of CIR/SCCS warnings.
- Ist sodium c12-15 pareth-7 sulfonate sicher für Babyhaut?
- No infant-specific reproductive or developmental hazards identified for this surfactant. However, immature infant skin has higher permeability and higher surface-area-to-weight, so exposure score is increased by +1 from adult (adult e=1 → infant e=2). No infant-specific adverse data found in regulatory or peer-reviewed sources. Sources: CosIng/PubChem (ingredient identity and typical use), ECHA (no harmonised classification), toxicology literature absence per CIR/SCCS practice.
- Wie bewertet VeriMom sodium c12-15 pareth-7 sulfonate?
- VeriMom bewertet sodium c12-15 pareth-7 sulfonate mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu sodium c12-15 pareth-7 sulfonate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu sodium c12-15 pareth-7 sulfonate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.